Clik here to view.
Drug price controls growing popular?
Bloomberg reports that Germany will soon levy over $2bn worth of price cuts on drug makers launching new products. Germany is the world’s third biggest pharma market after the US and Japan, it points...
View ArticleClik here to view.
Think different : Big Pharma and drug pricing in emerging markets
I’d like to introduce a guest column by Salil Kallianpur, a healthcare marketing professional with experience in the pharmaceutical and medical devices industries. Salil is an avid reader and follower...
View ArticleClik here to view.
FDI in pharma : another punch
The issue of controlling foreign direct investment (FDI) in the Indian pharmaceutical sector continues to make headlines with various arms of the government putting forth their own formulas to tame the...
View ArticleClik here to view.
India’s new drug pricing policy : will data be the stumbling block?
On December 7, India’s National Pharmaceutical Pricing Policy 2012 was finally tabled in Parliament. Assuming that this policy does get rolled out irrespective of a Supreme Court hearing on drug...
View ArticleClik here to view.
India & drug pricing : Now, list of essential meds questioned
In continuation of the challenges arising from the roll-out of India’s new drug pricing policy, a question has now been raised on the current National List of Essential Medicines (NLEM) that specifies...
View ArticleClik here to view.
Think deeper about drugs affordability : my column in the Indian Express
My latest column in The Indian Express addresses the question of drug affordability. In this column, I have argued that the new Drug Price Control Order (DPCO), soon to complete a year in existence,...
View ArticleClik here to view.
Indian #pharma policy : Missing the wood for the trees
The latest round of price interventions imposed on the drug industry by India’s National Pharmaceutical Pricing Authority (NPPA) has the industry fulminating. Just when it was recovering from being all...
View ArticleClik here to view.
India’s logic-defying drug pricing moves : My column in Quartz India
Just when I thought things were getting a bit dull, they go and do this.
View ArticleClik here to view.
India #Pharma 2014 : A quick look back. Part Three #pricing #nppa
The holiday season approaches, so here’s a quick look at the year that was for Indian Pharma, before we disappear into a haze of year-end festivities. It’s a mixed bag (what year isn’t?) including...
View ArticleClik here to view.
India #Pharma 2014 : A quick look back. Part Three #pricing #nppa
The holiday season approaches, so here’s a quick look at the year that was for Indian Pharma, before we disappear into a haze of year-end festivities. It’s a mixed bag (what year isn’t?) including...
View ArticleClik here to view.
India #Pharma 2014 : A quick look back. Part Three #pricing #nppa
The holiday season approaches, so here’s a quick look at the year that was for Indian Pharma, before we disappear into a haze of year-end festivities. It’s a mixed bag (what year isn’t?) including...
View Article
